Navigation Links
FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
Date:4/15/2008

- Phase II study extension shows 68-73% of patients with multiple sclerosis remained relapse-free after three years of treatment with oral FTY720 - New data demonstrate 89% of patients free from active brain lesions - the

injury caused by MS - three years after starting treatment - MS, a devastating disease causing progressive disability, affects 2.5

million people worldwide including many young adults

- FTY720 regulatory filings planned before end of 2009 in US and EU

EAST HANOVER, N.J., April 15 /PRNewswire-FirstCall/ -- The investigational oral therapy FTY720 (fingolimod) continues to demonstrate sustained benefits in patients with multiple sclerosis (MS) after three years of treatment, according to new clinical data presented today from an ongoing Phase II study extension.

Results showed that 73% of patients who began the study on FTY720 5 mg remained free from relapses after three years, and 68% of those who began the study on FTY720 1.25 mg remained relapse-free. The figures after two years of treatment were 77% and 75% respectively. On the basis of comparable efficacy and a better safety profile, all patients have been transferred to FTY720 1.25 mg in the study extension.

The 36-month data also showed an average annualized relapse rate of 0.20, equivalent to one relapse in five years, while 89% of patients were free of the active brain lesions characteristic of MS as measured by magnetic resonance imaging (MRI) three years after starting treatment.

The results were presented at the 60th annual meeting of the American Academy of Neurology (AAN) in Chicago, USA.

"These new data demonstrate the exciting potential for FTY720 to reduce relapse rates in MS patients with a convenient once-daily pill," said Professor Giancarlo Comi, Professor of Neurology at the University Vita-Salute San Raffaele in Milan, Italy. "An effective oral treatment would be a significant breakthrough in the managemen
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
2. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
3. Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
4. Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment
5. NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
6. Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan
7. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
8. Peptimmune Completes Phase I Study with a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
9. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
10. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
11. ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 Professional Compounding Centers ... medicine by awarding the three best scientific presentations ... (EuPFI) conference . The Formulating Better Medicines ... in Athens, Greece , includes ... and professionals, from which three winners will be ...
(Date:8/21/2014)... MENLO PARK, Calif. , Aug. 21, 2014 /PRNewswire/ ... company in the emerging field of regenerative medicine, announced ... ("Nat") Ricciardi to the Company,s newly expanded Board of ... now comprises eight directors, three of whom are independent. ... years of experience working with emerging growth companies. He ...
(Date:8/20/2014)... Aug. 20, 2014 The National Association ... latest results achieved by the real-time, pseudoephedrine (PSE) ... National Precursor Log Exchange (NPLEx), automatically blocks unlawful ... down meth offenders and make arrests. Data released ... Kansas blocked the sale of more ...
Breaking Medicine Technology:Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... 2011 Medizone International, Inc. (MZEI:OB MZEI:QB) reports ... Patent No 2735739 for processes and systems relating ... AsepticSure™ hospital disinfection product. Medizone,s ... significance of this Grant: "This foundational lead patent ...
... Leading event organiser UBM has announced a record ... pharmaceutical events including CPhI Worldwide for pharmaceutical ingredients, ... for equipment, machinery and technology and the new ... Frankfurt, Germany from the 25th to 27th October ...
Cached Medicine Technology:Canadian Patent Issued to Medizone International for AsepticSure™ Disinfection Technology 2Record Year for UBM's Pharma Events in Frankfurt 2Record Year for UBM's Pharma Events in Frankfurt 3Record Year for UBM's Pharma Events in Frankfurt 4
(Date:8/21/2014)... The results of a large, retrospectives ... of the American Medical Association (JAMA) show that 3D ... unnecessary recalls. Memorial Healthcare System was one of 13 ... study confirms what we already know – 3D mammography ... to find and, at the same time, saves women ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 According to ... “Home Audio Equipment (Product Types - Home Theatre in-a-box, ... Market - Global Industry Analysis, Size, Share, Growth, Trends ... at USD 15.94 billion in 2012 and is expected ... a CAGR of 3.7% from 2013 to 2019. Europe ...
(Date:8/21/2014)... Aug. 21, 2014 (HealthDay News) -- In a new ... pregnant women avoid eating tuna due to concerns about ... which is second only to shrimp as the most ... pregnant women to avoid all tuna," Jean Halloran, director ... division of Consumer Reports, said in a news release ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Pleio, ... adherence, is launching a new suite of services ... offerings assist retail pharmacy by applying proven behavior ... classes, resulting in increased medication adherence, higher PDC ... As such, Pleio’s PDC-targeted offerings align retail’s desire ...
(Date:8/21/2014)... scientific collaboration led by Baylor College of Medicine has ... a rare form of kidney cancer, providing new insights ... as well. , The collaboration, a project of the ... , completed the sequence of chromophobe renal cell carcinoma ... Cancer Cell . , "The Cancer Genome Atlas ...
Breaking Medicine News(10 mins):Health News:Dr. Mary Hayes: Study Shows 3D Mammography Finds More Invasive Cancers While Reducing Unnecessary Recalls 2Health News:Home Audio Equipment Market Expected to Reach USD 20.68 Billion in 2019 2Health News:Home Audio Equipment Market Expected to Reach USD 20.68 Billion in 2019 3Health News:Consumer Reports Advises Pregnant Women to Avoid Tuna 2Health News:Pleio, Inc. Expands Adherence Offerings For Retail Pharmacy 2Health News:Sequence of rare kidney cancer reveals unique alterations involving telomerase 2Health News:Sequence of rare kidney cancer reveals unique alterations involving telomerase 3
... researchers have for the first time miniaturised an important ... microfluidic chip . ,The new technology, developed ... the possibility of better, faster cancer treatment and greater ... test that detects mutations in chromosomes for a number ...
... A recent survey has found that parents are increasingly monitoring ... ,According to the Kaiser Family Foundation's national survey ... say that they "closely" keep an eye on their children's ... do more." ,"While parents are still concerned about ...
... device that mimics the naturally disinfecting quality of fresh ... radicals into the atmosphere , killing microbes within minutes. ... used to purge hospital wards of superbugs. ... all the windows of hospital wards, but that's not ...
... research, examining the upper echelons of the human brain's ... two corresponding commanders in charge of the brain . ... in St. Louis found that these two commanders are ... other but still work toward a common intention i.e. ...
... diet can increase the risks of bowel cancer. The research ... acid in the gut , due to the consumption of ... colorectal cancer, is produced by bacteria and helps in fighting ... found that the widely practised Atkins Diet -can lead ...
... was no point blaming China for rising carbon dioxide (CO2) ... have already become the world's biggest polluter. ,In ... of Britain's Foreign Office was quoted as saying: "It is ... every week". However, he went on to say that it ...
Cached Medicine News:Health News:Now, FISH on a Chip for Quicker, Cost-effective Cancer Diagnosis 2Health News:Parents are More Concerned on What Their Kids Watch 2Health News:New Device Developed to Eliminate Superbugs Within Minutes 2Health News:Two, Not One Networks Rule Brain's Voluntary Chain-of-command 2Health News:Two, Not One Networks Rule Brain's Voluntary Chain-of-command 3Health News:China Cannot Be Blamed for Rising CO2 Emissions: Britain Official 2
... plates in mind, Pipetman Ultra Multichannel ... applications: PCR* sequencing, immunology assays, series ... with Diamond Tips from Gilson's patented ... maximize performance and assure productivity.,* PCR ...
... variety of applications. • Whole pipette is autoclavable ... rotated against the handle to work in a ... towards the microtiter plate. • The special nose ... pipette tips, and provides a firm, parallel fit. ...
... precision, ergonomics, and value!, Comfortable feel ... contoured handle , Finer control while pipetting ... Stress-free tip ejection with long, lever tip ... and sterilization without the need for recalibration ...
... precision, ergonomics, and value!, Comfortable feel ... contoured handle , Finer control while pipetting ... Stress-free tip ejection with long, lever tip ... and sterilization without the need for recalibration ...
Medicine Products: